Korean J Ophthalmol.  2019 Dec;33(6):575-576. 10.3341/kjo.2019.0037.

Anti-N-methyl-D-aspartate Receptor Encephalitis in a Patient with Thyroid Eye Disease

• Kwak J
• Shin WB
• Ko JS
• Park SJ
• Yoon J

• KMID: 2465140
• DOI: http://doi.org/10.3341/kjo.2019.0037

Abstract

No abstract available.

MeSH Terms

Anti-N-Methyl-D-Aspartate Receptor Encephalitis*
Eye Diseases*
Humans
Thyroid Gland*

Figure

• 

  Fig. 1 Thyroid eye disease patient with anti-N-methyl-D-aspartate receptor encephalitis. Below are the axial views from orbital computed tomography. (A,B) Patient on the day of initial visit to the clinic. (C,D) Patient on the night of arrival to our emergency department. (E,F) Approximately 1 month after surgical orbital decompression and intravenous steroid and immunosuppressive therapy.

Reference

1. Bahn RS. Graves' ophthalmopathy. N Engl J Med. 2010; 362:726–738.

2. Behrendt V, Krogias C, Reinacher-Schick A, et al. Bortezomib treatment for patients with anti-N-methyl-d-aspartate receptor encephalitis. JAMA Neurol. 2016; 73:1251–1253.

3. De Leu N, Unuane D, Poppe K, Velkeniers B. Seizures and postictal stupor in a patient with uncontrolled Graves' hyperthyroidism. BMJ Case Rep. 2012; 06. 01. DOI: 10.1136/bcr.02.2012.5929.

4. Lu J, Samson S, Kass J, Ram N. Acute psychosis in a pregnant patient with Graves' hyperthyroidism and anti-NMDA receptor encephalitis. BMJ Case Rep. 2015; 04. 22. DOI: 10.1136/bcr-2014-208052.